219 related articles for article (PubMed ID: 15883621)
1. Current development of lentiviral-mediated gene transfer.
Romano G
Drug News Perspect; 2005 Mar; 18(2):128-34. PubMed ID: 15883621
[TBL] [Abstract][Full Text] [Related]
2. Lentiviral vectors: excellent tools for experimental gene transfer and promising candidates for gene therapy.
Vigna E; Naldini L
J Gene Med; 2000; 2(5):308-16. PubMed ID: 11045424
[TBL] [Abstract][Full Text] [Related]
3. Functional correction of fanconi anemia group C hematopoietic cells by the use of a novel lentiviral vector.
Yamada K; Olsen JC; Patel M; Rao KW; Walsh CE
Mol Ther; 2001 Apr; 3(4):485-90. PubMed ID: 11319908
[TBL] [Abstract][Full Text] [Related]
4. Cancer cells as targets for lentivirus-mediated gene transfer and gene therapy.
Pellinen R; Hakkarainen T; Wahlfors T; Tulimäki K; Ketola A; Tenhunen A; Salonen T; Wahlfors J
Int J Oncol; 2004 Dec; 25(6):1753-62. PubMed ID: 15547714
[TBL] [Abstract][Full Text] [Related]
5. [Lentiviral vectors].
Spirin PV; Vil'gelm AE; Prasolov VS
Mol Biol (Mosk); 2008; 42(5):913-26. PubMed ID: 18988539
[TBL] [Abstract][Full Text] [Related]
6. [Development of gene therapy for hematopoietic stem cell using viral vectors].
Dong WJ; Zu ZX; Liu DP; Liang CC
Yi Chuan Xue Bao; 2003 Apr; 30(4):382-8. PubMed ID: 12812066
[TBL] [Abstract][Full Text] [Related]
7. Non-primate lentiviral vectors.
Poeschla EM
Curr Opin Mol Ther; 2003 Oct; 5(5):529-40. PubMed ID: 14601523
[TBL] [Abstract][Full Text] [Related]
8. Latest developments in gene transfer technology: achievements, perspectives, and controversies over therapeutic applications.
Romano G; Michell P; Pacilio C; Giordano A
Stem Cells; 2000; 18(1):19-39. PubMed ID: 10661569
[TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus type 1 (HIV-1) derived vectors: safety considerations and controversy over therapeutic applications.
Romano G; Claudio PP; Tonini T; Giordano A
Eur J Dermatol; 2003; 13(5):424-9. PubMed ID: 14693483
[TBL] [Abstract][Full Text] [Related]
10. Lentiviral vector-mediated gene delivery into human embryonic stem cells.
Gropp M; Reubinoff B
Methods Enzymol; 2006; 420():64-81. PubMed ID: 17161694
[TBL] [Abstract][Full Text] [Related]
11. A roadmap to safe, efficient, and stable lentivirus-mediated gene therapy with hematopoietic cell transplantation.
Neschadim A; McCart JA; Keating A; Medin JA
Biol Blood Marrow Transplant; 2007 Dec; 13(12):1407-16. PubMed ID: 18022569
[TBL] [Abstract][Full Text] [Related]
12. Comparison of HIV- and EIAV-based vectors on their efficiency in transducing murine and human hematopoietic repopulating cells.
Siapati EK; Bigger BW; Miskin J; Chipchase D; Parsley KL; Mitrophanous K; Themis M; Thrasher AJ; Bonnet D
Mol Ther; 2005 Sep; 12(3):537-46. PubMed ID: 16099415
[TBL] [Abstract][Full Text] [Related]
13. Use of HIV as a gene transfer vector.
Pluta K; Kacprzak MM
Acta Biochim Pol; 2009; 56(4):531-95. PubMed ID: 19936329
[TBL] [Abstract][Full Text] [Related]
14. Gene transfer systems derived from Visna virus: analysis of virus production and infectivity.
Berkowitz RD; Ilves H; Plavec I; Veres G
Virology; 2001 Jan; 279(1):116-29. PubMed ID: 11145895
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy for neurodegenerative and ocular diseases using lentiviral vectors.
Ralph GS; Binley K; Wong LF; Azzouz M; Mazarakis ND
Clin Sci (Lond); 2006 Jan; 110(1):37-46. PubMed ID: 16336203
[TBL] [Abstract][Full Text] [Related]
16. Gene delivery into primary cerebral cortical neurons by lentiviral vector.
Zhang Y; Wang H; Pan H; Bao X; Li M; Jin J; Wu X
Cell Biol Int; 2006 Oct; 30(10):777-83. PubMed ID: 16872845
[TBL] [Abstract][Full Text] [Related]
17. Lentiviruses in gene therapy clinical research.
Connolly JB
Gene Ther; 2002 Dec; 9(24):1730-4. PubMed ID: 12457288
[TBL] [Abstract][Full Text] [Related]
18. Influenza M2 envelope protein augments avian influenza hemagglutinin pseudotyping of lentiviral vectors.
McKay T; Patel M; Pickles RJ; Johnson LG; Olsen JC
Gene Ther; 2006 Apr; 13(8):715-24. PubMed ID: 16397505
[TBL] [Abstract][Full Text] [Related]
19. Genetic modification of hematopoietic cells using retroviral and lentiviral vectors: safety considerations for vector design and delivery into target cells.
Dropulic B
Curr Hematol Rep; 2005 Jul; 4(4):300-4. PubMed ID: 16009045
[TBL] [Abstract][Full Text] [Related]
20. Human mesenchymal stem cells (hMSCs) expressing truncated soluble vascular endothelial growth factor receptor (tsFlk-1) following lentiviral-mediated gene transfer inhibit growth of Burkitt's lymphoma in a murine model.
Kyriakou CA; Yong KL; Benjamin R; Pizzey A; Dogan A; Singh N; Davidoff AM; Nathwani AC
J Gene Med; 2006 Mar; 8(3):253-64. PubMed ID: 16288493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
